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STATEMENT OF THE PROBLEM 
Recent interest in the use of oral contraceptive agents by humans has 
been high. Their widespread popularity as a convenient and efficient means 
of birth control, and as a therapeutic regime for various gynecological 
diseases has proven a stimulus sufficient to permeate the literature with 
documentation of the direct effects of these drugs on the welfare of the 
human organism. However, extensive research concerning drug effects on the 
natural course of bacterial disease has only recently begun to appear. 
It remain~ then for the researcher to leave no corner darkened in an 
attempt to delineate effects of these drugs insofar as they hold practical 
importance for their human users. The purpose of this work is a clarifica-
tion, through review and experimentation, of the ability of a specific 
contraceptive agent to modify the host-parasite relationship as it exists 
in human bacterial disease. 
1. 
INTRODUCTION 
Oral contraceptives by almost any medical yardstick are a new and largely 
unknown quantity. They represent the answer of twentieth century scientific 
know-how and technology to an anguished cry for help from a burgeoning world 
population. These drugs have brought to a close with door slamming finality 
a more traditional period of contraception through the promise of a new era 
. 
hallmarked by efficiency, low cost, simplicity and ease of administration, 
and safety. Of these factors only the latter has threatened to turn the 
panacea into a Pandora's box. 
Minor side effects accompanying the use of contraceptive drugs are 
common and inc~ude gastrointestinal disturbance, malaise, menstrual irregu-
1arities, rash, hirsuitism, alopecia, weight gain and chwasma to mention 
only a few (40). Possible complications of an inherently more serious nature 
include potential for the production of thromboembolism, and carCinogenesis. 
Despite lingering doubts it is estimated that in Australia and New 
Zealand 20% of women of reproductive age use oral contraceptives, whereas 
in the United States 12% are users and in the United Kingdom 3% (18). Pro-
jection of such figures calls for a dramatic increase in worldwide uti1i-
zation of oral contraceptives to the point that between 20 and 40 million 
of the world popUlation will control their fertility through this method 
by the year 1980 (18). Such use will no doubt be facilitated by development 
of new drugs with greater potency and fewer adverse effects. 
2. 
In addition it should be remembered that oral contraceptive drugs need 
not be used solely for family planning for they have proven a welcome addi-
tion to the therapeutic arsenal of the gynecologist. Therapeutic efficacy 
has been claimed not only in fertility control but in the treatment of such 
disease states as amenorrhea, dysmenorrhea, endometriosis and functional 
uterine bleeding. The value of contraceptives in the treatment of such 
conditions as menopausal syndrome, acne, chronic vulvar infections and psych-
iatric disorders remains a subject for further research (19). 
Of the oral contraceptive drug combinations in present day use a popular 
and representative example in Enovid. This drug consists of the synthetic 
progestogen Norethynodrel (17a ethynyl 17 hydroxy 5(10) estrene 3 one) and 
the synthetic estrogen Mestranol (17a ethynyl estradiol 3 methyl ether). 
Although these compounds are characterized biologically through differing 
effects their basic structure is remarkably similar (53). In fact, struc-
tural dissimilarities are limited to ring A of the steroid nucleus and to 
the chemical grouping substituted on carbon atom 3. Such a close correlation 
is reflected functionally since it is known that Norethynodrel, while having 
a high progestational activity possesses as well a low inherent estrogenic 
activity (6). 
In view of chemical details, then, it appears that a consideration of 
effects of steroid compounds in general is a necessary first step toward 
understanding the action of Enovid. The high electron affinities of steroids, 
a property unusual among organic compounds, may be an indication of their 
3. 
ability to participate in or control biological oxidative processes (13). 
One of the earliest observed effects of steroid hormones in vitro upon 
enzymatic systems was found to be the general inhibition of respiration 
effected by a variety of steroids in preparations from diverse sources (48). 
Specifically, it has been observed that steroid hormones inhibit the reduc-
tion of cytochrome C by NADH2 in intact mitochondria from rat liver cells. 
In addition, mitochondrial pa:ticu1ate preparations are known to exhibit 
steroid induced permeability changes. It is possible that an increase in 
permeability in mitochondrial membranes permits a loss of the NAD necessary' 
for respiratory functions. In rat liver mitochondria at least, steroid 
inhibition of respiration was found to be reversible upon the addition of 
NAD to the media (48). 
In a more immediate sense glucocorticoids are believed to function 
as passive antagonists of a stress activated intrinsic microcirculatory 
dilator and thus to oppose relaxation of microvascular sphincters. At the 
site of irritation dilator synthesis is increased and all small vessels are 
open. Corticoids by closing sphincters suppress the early hyperemia thereby 
preventing development of later phases of the inflammatory reaction. In 
the absence of corticoids mild stress activation of dilator synthesis leads 
to excessive opening of capillaries while greater activation leads to pooling 
of blood and circulatory failure (41). More recently such circulatory 
dilators have been identified and. characterized. Kinin,s are naturally 
occurring vasoactive polypeptides thought to be the mediators of the acute 
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inflammatory response. They are released from a plasma protein substrate 
by glass activated plasma enzymes (kallikreins) or by isolated intact granu-
locytes. Cortisol at a concentration of 2.5 x 10-5 M was found to prevent 
the release of active kinin by granulocytes or contact with glass. Deoxy-
corticosterone, progesterone and etiocholanolone in comparable concentrations 
were found significantly less effective in preventing kinin release (41). 
Cortisol also partially inhibited the release of kinin by purified urinary 
kallikrein. Thus certain steroids may possess anti-inflammatory effects by 
virtue of their ability to inhibit the release of plasma kinins. They seem 
able also to prevent interaction between activated kallikrein and its sub-
strate (11). 
Compounds 'that are able to alter the course of inflammation and affect 
such basic processes as cellular respiration might well be expected to influ-
ence the host-parasite relationship as it exists in human infectious disease. 
Due to the practical implications of such a contingency the effect of gluco-
corticoids on disease processes has been studied in detail. Both adreno-
corticotropic hormone (ACTH) and cortisone have been found to depress the 
resistance of laboratory animals to infectious agents, activate foci of 
latent infection and render animals susceptible to intection by ordinarily 
non-pathogenic flora. Infected animals may succumb to smaller doses of 
infective agent than do animals not receiving ho~mones; and, when given in 
conjunction With antibiotics the &teroids generally red~ce the effectiveness 
of a given dose of antibiotic. Factors induced by steroid administration 
s. 
which may play a role in decreased host resistance include a decrease in the 
local inflammatory response, increased multiplication of the pathogen and 
inhibition of phagocytosis and the capacity of the reticuloendothelial system 
to fix or remove bacteria and their toxins from tissue (24). Steroids reduce 
the rate of antibody synthesis and it has been found that the bactericidal 
capacity of leucocytes obtained from the peritoneal exudate of rats pre-
treated for 3 days with intr~uscular injections of cortisol displayed an 
impaired capacity to kill phagocytized organisms (3). 'In addition, wide-
spread dissemination characteristic of hormone treated animals may in some 
instances reflect the inhibitory effect of cortisone on the action of haylu-
ronidase (24). Mineralocorticoids apparently have less drastic erfects on 
the microbial world although it is known that deoxycorticosterone may markedly 
inhibit the growth of Neurospora crassa in a highly specific manner. In 
fact, growth of all Gram-positive bacteria, yeasts and molds are significantly 
affected by tnis compound (26). 
The effects of pregnancy on various disease states may be the res~lt of 
intrinsic physiologic change related to the economy of endocrine hormones 
whose concentrations rise dramatically in the gravid female (14). As a 
result these compounds, notably estrogens and progestogens, have been exten-
sively studied with respect to their effect on pathogenic microorganisms. 
Casas-Campillo demonstrated that 21-31 dimethoxyprogesterone effectively 
inhib£ted the growth of Curvularia lunata and Trichophyton mentagrophytes. 
Fungistatic effects were found to decrease with increasing complexity of 
" 
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the modifications on carbon atom 21 (10). Progesterone has been shown to 
have a bacteriostatic effect on staphylococci in vitro which correlated well 
with a significant reduction in the oxygen uptake (55). Yotis has carried 
this work a step farther by demonstrating that Norethindrone, a synthetic 
progestogen, has in vivo effects serving to protect infected animals against 
the formation of dermal lesions (54). Some workers feel that the inhibitory 
capacity of the sex hormones depends upon specific functional groups or 
chemical properties rather than merely on the general features of steroid 
structure (46). Information is accumulating to show demonstrable sex dif-
ferences in respect to immune responsiveness; the female being more respon-
sive than the male. In addition there is evidence that immune responsiveness 
is lower in the pregnant female ot most species inc1udin~ humans (16). In 
this regard it has been found that progestational agents increase the hazard 
from anapnylactic shock in rats. Hydroxyprogesterone caproate (De1a lutin) 
and 6a methyl 17 hydroxyprogesterone acetate have been found to delay the 
rejection of skin grafts in rabbits (51). 
The estrogenic hormone estrone increases the resi.stance of the castrated 
rabbit to vaccinia infection (45). Estradiol, however, has been found by 
other investigators to shorten survival time of animals infected with certain 
species of Aspergillus. This effect was correlated with leukopenia and 
relative neutropenia (31). Lurie found that in ~xperimenta1 infections with 
Mycobacterium tuberculosis, estrogens exerted a retarding effect on the 
growth of the lesion at the site of inoculation, diminished the extent of 
7. 
the disease in internal organs and suppressed its dissemination throughout 
the body (30). Conversely, the gravid state in white mice has been shown to 
increase their susceptibility to infection with streptococci (51). 
The effects of estrogen on the function of the reticuloendothelial 
system are well documented. It appears that the estrogenic molecule has 
two unrelated biological functions - modification of sexual organs and stim-
ulation of the reticuloendothelial system (34). Estrogens exert an adjuvant 
eftect on the primary immune response. Their ability to increase phagocytic 
ability, elevate serum gamma globulin levels and protect experimental animals 
against severe infection provide strong argument for a generalized arousal 
of body defenses. Several substances, including endotoxins, lipopolysac-
charides, lipid A and zymosan, are also capable of this action; but to date, 
the strongest reticuloendothelial system stimulants appear to be estrogens 
both natural and synthetic (35). Cortisone has been shown to act as an 
antagonist to estrogen in that it depresses phagocytic ability, the total 
and difterential white blood cell count and the serum levels of gamma ~lo­
bulin.In fact, if cortisone and estrogens are administered separately but 
simultaneously at separate sites, the depressant activity of cortisone is 
prevented and considerable stimulation of phagocytic activity occurs (17) •. 
Other reticuLoendothelial depressants include prednisone, 4 hydroxy tetra-
phenylmethane, cholesterol, ergosterol, stilbene (33) and ethanol (2). 
The basic mode of action in ~urrently marketed ora~ contraceptives is 
similar in all - the inhibition of ovulation and the initiation of periodic 
8. 
breakthrough bleeding. However, the potentiality of these compounds to 
affect human consumers is by no means limited to prevention of pregnancy. 
In an attempt to completely consider the drug modified human in his context 
as bacterial host, a brief review of metabolic effects is worthy of mention. 
It ~s now well established that the oral contraceptives inn~D~t ovulation 
predominantly at the pituitary level where they interfere with the synthesis 
and release of 1utenizing hormone. After cessation of therapy resumption of 
ovulation is prompt, with return of pituitary function within 6 to 8 weeks. 
Administration of Norethynodrel (1-5 mg per 100 g of body weight) to 
female white rats was found to produce striking effects in the adrenal glands. 
Histochemically, lipid was found depleted from the cortical zones while tne 
parenchymal cells of the zona glomeru1osa became smaller. Significant lipid 
depletion occurred in the zona fasicu1ata and reticularis after only 2 days 
of treatment (5). Total weight of the glands was found to be increased over 
that of controls. Corticosterone assays performed on adrenal cortices and 
plasma from treated animals indicated increased concentrations of hormone (6). 
In humans oral contraceptives have been observed to produce increased cortisol 
binding by serum proteins (23). Low levels of urinary 17 hydroxysteroids 
have been accounted for by Leach and Margulis (25) who observed a variable 
suppression of pituitary ACTH in response to treatment with progestin. 
Studies of thyroid function reveal that the majority of women taking 
oral contraceptives show increased blood levels of thyroxine binding glo-
bulin (TBG) as well as protein bound iodine (PBI) with a stmultaneous decrease 
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in the T3 RBC uptake. the PBI may rise into the hyperthyroid range on 
occasion. These thyroid effects are probably secondary to estrogen induced 
increase of the binding proteins, for in no instance, has clinical evidence 
of hyperthyroidism been reported. 
There is no good evidence that Enovid alters directly the diabetic 
state. However, in a few cases, some degree of difficulty in the management 
of diabetic patients has been reported in connection with Enovid therapy. 
One study has indicated that a high percentage of women taking Enovid for 
fertility control have impaired glucose tolerance. The incidence of abnormal 
test results is greater in women with a family history of diabetes than in 
those without such a history. It seems reasonable to associate this change 
in glucose tolerance with the "pseudo pregnancy" (15) induced by the drugs , 
since pregnancy has long been known as an efficient screening test for pre-
clinical diabetes mellitus. Viewed in this light it is possible that those 
women exhibiting impaired glucose tolerance during Enovid therapy and having 
a positive family history should be carefully followed in anticipation of 
the onset of overt diabestes mellitus. Specifically, this diabetogenic 
effect seems to be due more to the progestogenic component of the contra-
ceptive combination. 
Liver function is yet another parameter subject to alteration by the' 
oral contraceptives. These drugs may produce in certain patients clinical 
signs ;of jaundice and modifications in various tests of liver function indi-
cative of biliary stagnation and hepatocellular damage (40). These changes 
" 
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are apparently mild and reversible on discontinuation of hormonal therapy. 
Women who have had cholestasis of pregnancy or familial, congenital or ac-
quired defects of biliary secretion are most vulnerable (1). The capacity 
of certain synthetic steroids to induce abnormalities of liver function has 
been attributed to the unnatural structural configurations or chemical sub-
stitutions that characterize these compounds. For instance, the natural 
hormone progesterone has not been shown to have this action. The synthetic 
progestogens, however, have certain functional groups (e.g. the 17 alkyl 
groups) which are known to confer hepatotoxicity (23). In ad~ition, the 
natural hormone estradiol and related synthetic estrogens consistently impair 
the ability of the liver cell to excrete the dye bromsulpthalein -- a sen-
sitive test of ' hepatocellular function. The possibility of a potentiating 
effect of estrogenic and progestogenic compounds on liver function has not 
yet been thoroughly investigated (23). On a subcellular basis Norethynodrel 
was capable of producing alterations in certain hepatic drug metabolizing 
systems as measured in vitro. It should be noted that metabolic pathways 
most affected were those in which hydroxylated or oxidized products were 
formed. The nature of this inhibition appears to be competitive and may 
indicate that liver microsomal enzymes which catalyze certain aliphatiC or 
aromatic hydroxyl at ions of drugs and foreign compounds may also catalyze 
hydroxylation of progestogenic steroids. Evidence that such systems cata-
lyze nydroxylations of androgenic~ estrogenic and corti~osteroi~s has already 
been forthcoming. It is of interest that Norethynodrel seems to stimulate 
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only certain drug metabolizing enzymes and that progesterone does not have 
this action (22). Electron microscopic studies of tissue obtained at liver 
biopsy from women taking oral contraceptives showed consistent mitochondrial 
changes as evidenced by considerable enlargement and irregularity of shape. 
The normal inner membrane was partially replaced by systems of laminae 
oriented parallel to the long axis of the mitochondrion (4). 
Possibly a less significant metabolic effect with regard to serum copper 
levels has been reported by Carruthers (9). He was able to demonstrate a 
marked increase in the serum copper and ceruloplasmin levels in 25 female 
subjects taking oral contraceptives. The correlation between copper and 
ceruloplasmin concentration together with the finding of normal urine copper 
levels in 10 subjects suggested that the increased serum copper was due to 
increased ceruloplasmin synthesis. 
In a study of 36 patients receiving oral contraceptives, Strauss and 
Pochi (41) found a significant decrease in sebum production. Separate admin-
istration of drug components revealed the effect primarily due to the estro-
gen. Suppression of sebaceous gland activity was found to be directly 
correlated with improvement in acne vulgaris. Indeed, recent clinical 
trials indicate striking effects of contraceptive drugs on dermal abcesses 
complicating acne (37). 
Of all the possible effects attributable to oral contraceptives the 
tendency to thromboembolic phenome~a has remained one of the most enigmatic 
and potentially lethal. Although there have been many studies by competent 
12. 
investigators the results have proven conflicting and divergent. It is 
known that certain of the clotting factors such as fibrinogen and factors 
VII to X are elevated in women consuming oral agents on a long term basis 
(12,32). Unfortunately, even though many of the factors in the blood con-
cerned with clotting can be ascertained, their elevation is not a measurement 
of hypercoagulability. For example, although fibrinogen and factors VII to X 
are elevated in pregnancy, thromboembolism occurs most commonly in the 
puerperium when levels of these factors have returned to normal. At present 
all that may be said is that available statistics show no clear cut relation-
ship between contraceptive administration and the production of thrombo-
embolism. Indeed the Food and Drug Administration's advisory committee on 
obstetrics and 'gynecology has recommended a long term, carefully designed 
epidemiologic study to shed light on this problem. 
Other long term effects presently being scrutinized include the possible 
participation in tumorigenesis •. In experimental animals there is abundant 
evidence for such a role. Ovarian granulosa cell tumors have been induced 
in BALB mice by administration of 19-nor progesterone (21), progesterone 
(27), Norethindrone and Norethynodrel (28). The neoplastic faculty of the 
synthetic 19 nor-progestogenic steroids appears superior to that of the 
natural progesterone. Progesterone and 19 nor-progesterone contraceptives 
have also been shown capable of producing uterine malignancy, characteris-
tically a sarcoma, in experimenta~ animals. Similar tumors have been found 
in women receiv{ng 19-nor progestogenic agents (29). 
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Estrogenic compounds have also been implicated in the production of 
neoplasia involving cervix, endometrium, ovary, breast, testicle, pituitary, 
kidney and bone marrow in laboratory animals (1). However, it must be 
remembered that animal studies in which certain susceptible strains and 
species are used and excessive dosages are employed, cannot be readily and 
accurately applied to the situation regarding human beings. Such data does 
serve to inject a note of cau;ion and emphasizes the need for good, long 
term statistical studies. 
14. 
MATERIALS AND METHODS 
Cultures. The following microorganisms were used -- Staphylococcus 
aureus serotypes 1-13, Smith Diffuses strain, Rose strain and strain 209. 
These organisms were kept in stock at 4 C on tryptic soy agar (Difco) slants 
in screw capped tubes. Transfer to a new slant was made every four weeks. 
Cultures were checked periodically for morphology, anaerobic utilization of 
glucose and mannitol, free and bound coagulase, pigmentation and gelatin 
liquefaction by accepted microbiologicai procedures (44). In addition, 
inocula were screened before and after individual experiments for contam-
inants by Gram staining and the production of coagulase as measured by its 
ability to clot citrated plasma (Difco) . 
. 
Hormone .. Powdered pure Norethynodrel and Mestranol were obtained from 
the Searle Drug Company. Fresh solutions were prepared by dissolving 20 mg 
of Norethynodrel in 10 ml of 95% ethanol and immediately transferring 1 ml 
of the solution to 49 ml of tryptic soy broth (Difco) in 300 ml nephelometric 
flasks, yielding a final concentration of 40 ~g hormone per ml of growth 
medium. Control flasks received 1 ml of 95% ethanol. Both sets of flasks 
were then sterilized by autoclaving. For animal inoculation 10 mg of 
Norethynodrel and 5,mg of Mestranol were dissolved together in 10 ml of 
95% ethanol. Of this solution .1 ml was mixed with 9.9 ml of sterile saline 
to arrive at a solution containing 10 ~g/ml of Norethynodrel and 5 ~g per ml 
of Mestranol. Mice were injected intraperitoneally with .25 ml of the above 
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solution. Control animals received 0.25 ml of 1% ethanol in saline by the 
same route and at the same time. 
When animals were injected intravenously with bacteria and hormone 
simultaneously the hormone was dissolved in ethanol and a 1% solution pre-
pared as described previously. ~ aureus previously grown at 37 C for 18 hr 
was then harvested by centrifugation and added to the solution. Adjustment 
to the desired bacterial density was accomplished by subsequent dilution with 
hormone solution. At no time were bacteria suspended in hormone solution 
for periods greater than one hr prior to use. 
Growth studies. Cells used in growth studies were .grown in 10 ml of 
3% tryptic soy broth (Difco) at 37 C for 18 hr and harvested by centrifu-
gation. A smooth suspension was prepared by manual shaking for 1 min and 
was then adjusted with sterile saline (0.9%) to 10 Klett units by use of a 
No. 42 filter in a Klett-Summerson photoelectric colorimeter. This bacterial 
density corresponded to approxUnately 7 x 106 viable cells per mI. Each 
nephelometric flask was inoculated with 1 m1 of the above suspension and 
incubated aerobically in a walk-in incubator on a rotary shaker at 37 C, or 
anaerobically in a stationary carbon dioxide incubator at a similar temper-
ature under 2.5 atmospheres of pressure (C02), 
Growth was estimated turbidimetrically at varying time intervals using 
the Klett-Summerson photoelectric colorimeter and previously prepared stan-
dard curves. Under these conditi~ns 1 Klett unit was equivalent to 1.5 plus 
or minus 0.3 ~g dry weight of cells per mI. 
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Animal work. All mice and rabbits were obtained from Abrams Small Stock 
Breeders, Chicago, Illinois. The mice were maintained on a diet of Rockland 
Mice Pellets and the rabbits on Dixie Rabbit Pellets. All animals received 
food and tap water ad libitum. 
White Swiss female mice, each weighing between 18 and 22 g, were used 
in all work. These mice were prepared by intraperitoneal inJection of a 
0.25 m1 volume of solution containing 2% ethanol and varying concentrations 
of hormone prepared as above. On the fourth day the mice received a bacterial 
suspension in a solution containing hormone and adjusted to 450 Klett units. 
This suspension was administered through the dorsal tail vein in a total 
volume of 0.25 m1 which had been adjusted to the desired hormone concentra-
tion. Mice were observed for three days after infection and the number of , 
deaths on each day recorded. 
New Zealand female rabbits, 6 months old and weighing between 2.7 and 
3.2 kg, were used in all experiments. These animals were prepared by shaving 
bilateral paravertebral areas of skin approximating 9 sq. in,. Subseque~t1y 
they received at this site daily subcutaneous injections of varying quan:-
tities of hormone for periods of between 5 and 14 days. They were finally 
challenged by injecting into the marginal ear vein ~ aureus suspended in a 
total volume of 1 ml of hormone solution. The amount of hormone administered 
was equivalent to that given on any previous ind~vidua1 subcutaneous injec-
tion. ; Total white blood cell counts were made by the use, of a conventional 
white cell counting chamber, pipette and acetic acid (2.5%) diluent. 
'. 
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Relative quantities of neutrophils and lymphocytes were estimated under the 
oil immersion lens of the light microscope using Wright's stain and phosphate 
buffer (44). The first 100 white cells were counted at random in three 
widely separated areas of the same slide and standard hematological criteria 
based on size, shape, cytoplasmic granulation and nuclear morphology were 
used to identify various cells. Blood counts, both before and after bacterial 
challenge, were compared with suitable control values. In addition, samples 
of whole blood were aseptically drawn at various periods after infection from 
the marginal vein of the ear opposite to that used in inoculation. These 
samples were then diluted in sterile saline in a ten-fold continuum. Pour 
plates were made with 0.5 ml of the appropriate dilutions using tryptic soy 
agar (Difco) and placed in a 37 C stationary inc~bator for 48 hr. The , 
number of colonies was then counted and the results expressed as colony 
forming units per ml of blood. 
Bacterial counts. Mice were selected at random at 2, 4, 6, 18 and 24 hr 
after intravenous infection and sacrificed with ether. Utilizing sterile 
techniques the spleen, kidney, lungs and liver were excised and homogenized 
for 1 min with a Contorque power unit and 10 m1 tissue grinders (Thomas 
teflon pestle model). The resulting homogenate was then prepared by serial 
ten-fold dilution in sterile saline (0.9%) and plate counts of viable organ-
isms made as described above. Prior to homogenization organs were immersed 
in sterile saline (0.9%) and the volume of tissue estimated by observing the 
displacement of fluid in calibrated vessels. Results were expressed as 
colony forming units per organ and per ml of tissue. 
18. 
In all studies outlined above adequate controls were maintained. In 
animal work the drugs were administered in dosages calculated to approximate 
as nearly as possible on a per unit weight basis those dosages routinely 
administered to human beings. 
19. 
RESULTS 
Growth studies. Turbidimetric assessment of the in vitro growth of 
S. aureus indicated a strong inhibitory action of Norethynodrel being most 
noticeable in the early or lag phase of the growth curve and persistent to 
some extent over a period of 8 hr (Table 1). It should be noted that 
Norethynodrel in dosage limited only by its solubility (40 ~g per ml) evi-
denced a dose response relationship approximating linearity over the time 
period studied. After 8 hr of growth the inhibitory effect was found to 
decrease rapidly until at 12 hr in almost all instances no significant dif-
ference was discernible between flasks containing the hormone and the con-
trols. 
The effect of Norethynodrel on the in vitro growth of ~ aureuS in 
tryptic soy broth with regard to size of inoculum is emphasized in Table 2. 
Norethynodrel (40 ~g per ml) produced an inhibitory effect on growth at an, 
initial inoculum of 0.1 ml of 10 Klett units, much as in the first table. 
By varying bacterial density in the initial inoculum in 'an increasing manner 
growth curves were obtained which tended to confirm the inhibitory effect 
of Norethynodrel. Moreover it appeared that a larger inoculum size did not 
change the bacteriostatic effect while accelerating both its appearance and 
disappearance in the course of bacterial growth, a simple skewing of the 
curve to the left. 
In an attempt to identify the specific portion of the growth curve at 









EFFECT OF NORETHYNODREL ON THE GROWTH OF 
STAPHYLOCOCCUS AUREUS IN TRYPTIC SOY BROTH 
Average Klett readings at varying 
hormone concentrations 
growth o I-Lg/ml 20 j..Lg/ml 40 j..Lg/ml 
2.3 0.54 0.46 
4.9 1.2 0.9 
44.0 30.0 18.0 
113.0 94.0 73.0 
0.1 ml of a suspension containing 10 Klett units 
of ~ aureus (serotypes I-XIII, strain Rose, strain 
Smith and strain 209). 
Incubation: Rotary shaker at a constant temperature of 37 C. 
Results: Average of values obtained with serotypes I-XIII, 




EFFECT OF NORETHYNODREL ON THE GROWTH OF 
STAPHYLOCOCCUS AUREUS IN TRYPTIC SOy BROTH 
WITH REGARD TO THE SIZE OF INOCULUM 
Size of Inoculum (Klett Units) 
10 100 200 
Hours of 
Growth Control Hormone Control Honnone Control Hormone 
3 5 0 30 16 50 28 
4 20 8 56 26 110 80 
6 75 48 128 101 191 170 
, 
8 115 95 170 160 246 245 
Inoculum: 0.1 ml of a suspension of ~ aureus (serotypes I, II, III) 
with a variable bacterial density as indicated above. 
Incubation: Rotary shaker at a constant temperature of 37 C. 
Hormone: Norethynodrel adjusted to a concentration of 40 ~g/ml. 
Results: Expressed in Klett units of bacterial density at various 
time periods after inoculation. Each result is the average 
value obtained with serotypes I, II, III. 
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of several flasks at varying time intervals after inoculation with S. aureus. 
It may be seen in Table 3 that each addition was effective in producing a 
strong inhibition of bacterial growth up to 7 hr after inoculation with 
S. aureus. 
In view of the fact that any drug exerting effects on a living organism 
must do so in a millieu of other chemically active substances, growth studies 
were conducted utilizing Norethynodrel in combination with another steroid 
hormone. The presence in the media of such compounds as estradiol, testo-
sterone, deoxycorticosterone, Sa-pregnane, pregnenolone and progesterone in 
concentrations of 20 ~g/ml was not found to modify the action of Norethy-
nodrel. The situation was different, however, with regard to Norethynodrel 
and hydrocortisone. Table 4 illustrates the fact that a combination of 
Norethynodrel" (20 ~g per ml) and hydrocortisone (20 ~g per ml) effected 
bacteriostasis to a greater degree than either compound alone at a similar 
concentration. Thus, a synergistic effect of these steroidal compounds, . 
one upon the other is noted. 
The fact that the growth inhibition induced by Norethynodrel is not a 
lasting one, but is dependent upon the continued presence of the compound 
in the media, is illustrated in Table 5. Bacteria were incubated in broth 
containing hormone at a concentration of 40 ~g per ml for a period of 18 hr. 
The organisms were then harvested, washed and used as inocula for hormone 
and control flasks prepared as in ,previous studies. Results reveal no dif-
















EFFECT OF NORETHYNODREL ON THE GROWTH OF 
STAPHYLOCOCCUS AUREUS IN TRYPTIC SOY BROTH 
WITH REGARD TO THE Tn1E OF ADDITION OF HORMONE TO MEDIA 
Hormone Hormone Hormone Hormone 
added at added at added at added at 
Control 2 hr 4 hr 6 hr 7 hr 
0 0 0 0 0 
20 0 18 20 20 
70 40 30 70 70 
280 242 204 241 275 
0.1 m1 of a suspension containing 10 Klett units of 
S. aureus (serotype III). 
Rotary shaker at a constant temperature of 37 C.' 
Expressed in Klett units of bacterial density at various 
time periods after inoculation. 
24. 
TABLE 4 
POTENTIATION BY HYDROCORTISONE OF THE EFFECT OF NORETHYNODREL ON 
THE GROWTH OF STAPHYLOCOCCUS AUREUS IN TRYPTIC SOY BROTH 
Klett readings at various times 
Hormone 2 6 9 
Control (Ethanol - 2%) 3 29 80 
Norethynodrel - 20 ~g/ml 0 3 54 
Hydrocortisone - 20 ~g/ml 0 15 75 
Norethynodrel - 20 ~g/ml 0 0 25 
Hydrocortisone - 20 ~g/ml 
Norethynodrel - 40 ~g/ml 0 0 40 
Inoculum: 0.1 ml of a solution containing 10 Klett units of 
S. aureus (serotype III). 













EFFECT OF NORETHYNODREL ON THE GROWTH OF 
STAPHYLOCOCCUS AUREUS GROWN PREVIOUSLY 
IN TRYPTIC SOY BROTH WITH NORETHYNODREL 
Klett reading with inoculum Klett reading with inoculum 
grown in the absence of grown in the presence of 
Noreth~odre1 Noreth~odre1 
Control Hormone Control Hormone 
0 0 0 0 
7 4 5 4 
57 33 60 31 
115 75 115 76 
0.1 m1 of a solution containing 10 Klett units of s. aureus 
(serotypes IV, V, VI, VIII, IX, XI, XII) which had~een­
maintained for 18 hr in broth containing either hormone 
or 2% ethanol. 
Rotary shaker at a constant temperature of 37 C. 
Norethynodrel at a concentration of 40 ~g/ml. 
26. 
.:: 
organisms previously grown in the presence of Norethynodrel as compared to 
those grown in the presence of the hormone vehicle alone. 
In Table 6 the effect of Norethynodrel on anaerobic staphylococcal growth 
can be seen. Single determinations of bacterial density at 24 hr after in-
oculation indicate a striking growth inhibition of S. aureus serotypes II 
and III. In this instance a maximal effect was approximated with a smaller 
concentration of Norethynodrel (20 ~g per ml) than was found to be the case 
under aerobic conditions. 
Clearance studies. The in vitro growth prompted exploration of the 
possible in vivo effects of contraceptive agents. Table 7 represents the 
effect of Enovid administration on the recovery of ~ aureus (serotypes III, 
IX and XIII) from selected murine viscera at varying periods after intra-
venous bacterial challenge. In both spleen and kidney recovery of viable 
organisms was quantitatively reduced in those animals pretreated with Enovid, 
for a period encompassing the 6 hr after infection. At 18 hr after infec-
tion this effect was still noticeable. Similar clearance studies in mice 
revealed no such effect in liver and lung, nor were Norethynodrel or 
Mestranol individually capable of suppressing bacterial recovery. 
Since it was felt that a decreased ability to recover viable organisms 
from viscera of hormone treated animals might be due to a decreased avidity 
of the reticuloendothelial system, a study of experimentally induced bac-
teremia in the rabbit was underta~en. In Table 8 it may be seen that with 










EFFECT OF NORETHYNODREL ON THE ANAEROBIC GROWTH OF 
STAPHYLOCOCCUS AUREUS 
Klett readings with varying hormone concentrations 
0 20 40 
15.0 12.5 10.0 
51.5 19.0 6.0 
66.5 15.0 16.5 
(\-Lg/ml) 
1 ml of a solution containing 10 Klett units of S. aureus 
(serotypes I, II, III). 
In a C02 stationary incubator at 2.5 atmospheres of pressure 
and 37 C. 





FATE OF STAPHYLOCOCCUS AUREUS IN THE SPLEEN AND KIDNEY 











Colony forming units per m1 of tissue homogenate 
Spleen Kidney 
Control Hormone Control Hormone 
2.9 x 106 1.6 x 106 3.6 x 104 2.4 x 104 
3.4 x 106 1.5 x 106 4.9 x 104 2.3 x 104 
3.8 x 106 1.9 x 106 1.9 x 105 5.1 x .104 
7.4 x 105 4.1 x 105 3.7 x 106 2.9 x 106 
450 Klett units of ~ aureus (serotypes III, IX, XIII). 
5 ~g Norethynodrel intraperitonea11y for 5 days and 2.5 ~g 
Mestranol in the same manner. On the day of bacterial 
challenge the drugs were administered intravenously in 
the same dosage. 






EFFECT OF ENOVID ON EXPERIMENTALLY INDUCED 
BACTEREMIA IN THE RABBIT 
Colony forming units per m1 of blood at varying 
intervals (hr) after intravenous infection 
2 4 6 
157 1670 673 
246 146 755 
Inoculum: 1 m1 of a suspension containing 400 Klett units of 
~ aureus, serotype III injected intravenously. 
Hormone: Each rabbit received a total of 4000 ~g Norethynodrel 
and 150 ~g Mestranol subcutaneously over a period of 
10 days. 
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from the circulating blood were remarkably similar in both control and 
hormone treated animals. 
Mortality studies. These results would be of limited value if they did 
not correlate with the clinical response of the host to staphylococcal chal-
lenge. Consequently, hormone treated mice were observed for three days after 
infection and the time of their death noted. The results in Table 9 show 
that animals receiving a combination of Norethynodrel and Mestranol suffered 
fewer lethal infections on a percentage basis over the period of observation 
than did the control group. This protective action was most noticeable during 
the 24 hr immediately following infection when only 1070 of hormone treated 
animals died as opposed to 33% of controls. 
Blood studies. Norethynodrel was administered to white female rabbits ~ 
in the hope of determining its capacity to modify the total white blood cell 
count and differential count, either before or after bacterial challenge. 
The results expressed in Table 10 suggest that there was no consistent dif-
ference between control and hormone treated animals in this respect. 
31. 
TABLE 9 
EFFECT OF NORETHYNODREL AND MESTRANOL IN COMBINATION ON THE 













450 Klett units of ~ aureus, serotype III. 
20 ~g Norethynodrel and 10 ~g Mestranol over a four day 
period. 
Expressed in percentage of total animals dying at various 
periods after intravenous infection. 
32. 
TABLE 10 
EFFECT OF NORETHYNODREL ON THE WHITE BLOOD CELL COUNT IN THE RABBIT 
Hormone Control 
Group Total N L Total N L 
Blood count before drug 
administration 10,025 32 68 ~2,640 43 57 
Count after Norethynodrel 
200 'tlg/5 days 9,675 27 73 13,500 56 44 
Count 24 hr after giving 
220 Klett units 9,200 64 36 9,200 68 32 
Total N L Total N L 
Blood count before drug 
administration 7,275 30 70 7,200 52 48 
Count after Norethynodrel 
4000 'tlg/IO days 8,000 46 54 8,000 41 59 
Count 24 hr after giving 
300 Klett units 28,850 76 24 16,700 62 38 
Method: All hormone was given subcutaneously. Bacteria were given 
intravenously. 
Results: Expressed in total white blood cells per cubic ml of blood. 
N indicates percentage neutrophils and L percentage lymphocytes. 
33. 
DISCUSSION 
The inhibitory action of Norethynodrel on the growth of staphylococci 
is a phenomenon not without experimental precedent. Similar effects have 
been attributed to progesterone (55) and the synthetic progestogen Norethin-
drone (54). The mechanism of such effects remains open to speculation. 
There is some evidence to indicate the possibility that progestogens, both 
natural and synthetic, may interfere with membrane permeability and active 
transport (48), and in so doing deprive cells of needed nutrients. Alterna-
tively, it has been shown that progesterone may slow oxidative processes by 
impeding the flow of electrons in the cytochrome system resulting in a de-
crease of available cellular energy for support of growth and anabolic 
processes (24,48,50). Militating against such conclusions is the fact that 
anaerobic growth of S. aureus only served to accentuate the inhibitory effect 
of Norethynodrel (Table 5). 
An interesting result consistently observed in the present studies was 
the manifest tendency of Norethynodrel to quell bacterial proliferation most 
efficiently early in the growth cycle, with a rapid subsidence of action 
after 8 hr of growth (Table 1). It must be remembered that at the onset of 
growth the concentration per organism of the hormone initially added is a 
maximum quantity. However, variation in the number of organisms in the 
initial inoculum did not appear to affect the magnitude of growth inhibition 
(Table 2), but only served to produce a simultaneous skewing of the zones 
~. 
of growth inhibition and the growth curve itself without affecting their 
temporal interrelationships. 
Cells in the log phase are multiplying at a rapid pace and consequently. 
are characterized by accelerated patterns of metabolism -- a critical period 
for exposure to metabolic inhibitors and antagonists. By adding Norethy-
nodrel to varying portions of the growth curve (Table 3) inhibitory effective-
ness was found prominent throughout the first 7 hr of growth. This data 
shifts emphasis from the quantity of organisms present to their metabolic 
state and activity which at this time is beginning its entrance into the 
phase of deceleration of growth. 
In addition it is quite possible that such actively metabolizing and 
proliferating cells achieve the quantitative ability to modify the hormones 
in some way so as to neutralize its antibacterial action. 
Finally, it may be adduced that Norethynodrel exerts its effect 
throughout the growth curve. The dwindling difference between hormone 
treated and control flasks thus would be attributable not to progressive 
failure of hormonal inhibition late in the cycle, but to progressive inhi-
bition of the growth of control organisms in the presence of accumulating 
toxic metabolites and depleted stores of nutrient. Such a phenomena probably 
does occur to an extent. However, the possibility of growth inhibition after 
7 hr has been effectively ruled out by the results illustrated in Table 3,· 
Characteristically exposure of staphylococci to Norethynodrel in vitro 
.. -
induces no lasting change since upon reisolation the organisms do not ex-
hibit any alteration in growth patterns or heightened susceptibility to 
35. 
subsequent hormonal exposure (Table 5). The significance of such data is 
twofold. Firstly, the in vitro growth inhibitory effect is readily reversible 
Secondly, the ability of the staphylococcus to overcome this inhibitory 
effect may not be attributed ~o the emergence of, or the selection of, org-
anisms possessing a metabolic constitution resistant to the effects of 
Norethynodrel. 
In vivo experimentation utilizing white female mice revealed a quanti-
tatible reduction in viable organisms recoverable from the spleen and kidney 
in those animals pretreated with Enovid (Norethynodrel and Mestranol). 
Since the dose, period of administration and time interval following injec-
tion have been shown to be of outstanding importance for the effect of hor-
mones on the c6urse of infection (49,52), these factors were carefully 
regulated and dosages chosen to approximate on a weight basis those given 
to human beings. Methods of bacterial challenge are equally important, 
however, and the course of experimentally induced bacteremia in laboratory 
animals has been carefully reviewed by Rogers (38). Contrary to popular 
belief most microbes are less capable of provoking disease when injected 
intravenously than when they are administered by any other route. Rogers 
divides the bacteremia which ensues into 3 phases. The first phase, between 
10 min and 5 hr after infection, is characterized by the disappearance of 
90 to 99.9% of the circulating bacteria. The second phase may last from 
4 hr to several days; and dependi~g on the animal and the pathogen, micro-
organisms may persist in the circulation at lower concentrations or be 
36. 
removed at slower rates. During the third phase bacteria producing fatal 
infections reappear in the peripheral blood in large quantities and persist 
until the death of the animal. In the event of survival there may be a 
temporary rise in blood levels of bacteria with subsequent complete clear-
ance. The virulence of the organisms in question largely governs the late 
blood findings. 
Certain cells of the reticuloendothelial system, the ~upffer cells 
lining liver capillaries and phagocytic cells in splenic sinuses, are the 
most important sites of initial clearance of bacteria (7). Microbes are 
removed at a constant rate characteristic for the bacteria and the uptake 
by organs is related in a definite manner to their disappearance from the 
bloodstream. It is during this first phase of bacteremia that Norethynodrel ~ 
was found effective in reducing the quantity of recoverable organisms in 
spleen and kidney (Table 8). In view of what has been said above such a 
phenomenon could be due to an increased avidity of the blood for the organ-
isms, decreased uptake by the fixed phagocytes of the reticuloendothelial 
system or a more rapid killing of ingested organisms by the phagocytizing 
cell. 
Several workers have found that pathogenic staphylococci possess the 
capability to remain viable within phagocytes for several hours after inges-
tion (39,42,43). A differential effect due to intracellular killing within 
the fi~st 2 hr of infection would .appear unlikely •. Studies on levels of 
bacteremia in rabbits as well as total white blood cell counts and 
~. 
differential counts have consistently revealed no difference between rabbits 
treated with hormone and control animals (Tables 9, 10). Thus it would 
appear that phagocytic ability of the white blood cell has not been altered 
either quantitatively (4) or qualitatively. 
Decreased phagocytic ability of the fixed phagocytes of the reticulo-
endothelial system is a possible explanation. However, the mechanism of 
such an action or why it should selectively affect only cells of the spleen 
and kidney is obscure and could be dependent on local humoral or anatomic 
factors. Although during phagocytosis by leucocytes there is a large in-
crease in the oxygen uptake, most of this does not yield energy for the 
process of ingestion (36). In fact, Brogan has shown that the serum inde-
pendent mechanism of phagocytosis relies almost completely on glycolytic 
energy (8). Thus demonstrated effects of progesterone on electron transport 
may not be invoked as an explanation here (50,53). 
Whatever the mechanism, the end result is apparently a decreased 
mortality in mice protected by hormone (Table 8). Experimental evidence 
suggests that bacteremia persists or resurges into the "third phase" only 
when there is active seeding of the bloodstream (38). There is some indi-
cation that certain bacteria may reseed the circulation from the reticulo-
endothelial tissues in which they are originally sequestered. If indeed such 
sequestration is prohibited, or if sequestered organisms are rendered non-
viab1e.then it might reasonably b~ expected that reseeding and mortal dis-
semination could be delayed or prevented. Decreased deposition and 
38. 
proliferation of pathogenic organisms in vital organs such as the kidney 
may prolong life by decreasing the probability of resurgent bacteremia and 




The effect of Norethynodrel on the growth of S. aureus was studied 
in vitro; and the effect of the combination of drugs, Norethynodrel and 
Mestranol (Enovid) on the course of in vivo bacteremia was determined. The 
results may be summarized in the following manner: 
1. Norethynodrel inhibits the growth of a variety of serotypes of 
S. aureus in vitro. 
2. This effect is most marked in the lag phase of growth but persists 
well into the exponential portion of the growth curve. 
3. Hydrocortisone and Norethynodrel in combination were able to pro-
duce a greater degree of growth suppression than either drug alone. 
4. Growth in a C02 atmosphere potentiates the inhibitory effect of . 
Norethynodrel. 
5. The combination of Norethynodrel and Mestranol reduces the viable 




1. Advisory Committee on Obstetrics and Gynecology, Food and Drug Adminis-
tration. 1966. FDA report on the oral contraceptives, p. 1-13. 
U. S. Government Printing Office, Washington, D.C. 
2. ALI, M.V. and J.P. NOLAN. 1967. Alcohol induced depression of reticulo-
endothelial function in the rat. J. Lab. Clin. Med. 70:295-301. 
3. ALLISON, F. and M.H. ADCOCK. 1964. The influence of hydrocortisone and 
certain electrolyte solutions upon the phagocytic and bactericidal 
capacity of leucocytes obtained from peritoneal exudate of rats. 
J. Immunol. 92:434-445. 
4. ANBERG, A. 1967. Hepatic influence of oral contraceptives. 
Unpublished preliminary communication. 
5. BAKER, B.L., R.H. KAHN, and D.B. ZANOTTI. 1965. Influence of Norethy-
nodrel on the adrenal cortex of rats. Endocrinol. ZL:155r16l. 
6. BAKER, B.L., R.H. KAHN, D.B. ZANOTTI, and M. HEADINGS. 1966. Influence 
of Norethynodrel on the level of corticosterone in the adrenal 'glands 
and blood of rats. Endocrinol. 79:1095-1099. 
7. BOYD, W.C. 1966. Fundamentals of Immunology, p. 88-100. John Wiley 
and Sons, New York. 
8. BROGAN, T.C. 1966. Mechanisms of phagocytosis in human polymorpho-
nuclear leucocytes. Immunol. !Q:137-l47. 
41. 
9. CARRUTHERS, M.E., C.B. HOBBS, and R.L. WARREN. 1966. Raised serum 
copper and caeruloplasmin levels in subjects taking oral contra-
c~ptives. J. Clin. Pathol. ~:478-500. 
10. CASAS-CAMPILLO, C.D. BALABRANO, and A. GALARZA. 1961. Antimicrobial 
properties of al-al-dimethoxyprogesterone and other progesterone 
analogs. J. Bacteriol. 81:366-375. 
11. CLINE, M.J. and K.L. MELMON. 1966. Plasma kinins and cortisol, a 
possible explanation of the anti-inflammatory action of cortisol. 
Science ~:1135-ll5l. 
12. COWAN, L.F. 1967. Clinical evaluation of a new sequential oral con-
traceptive agent. Can. Med. Assoc. J. ~:1208-l2ll. 
13. DIXON, F.P., G.H. GRAY, and V.P. QUINESY. 1964. The action of steroid ~ 
hormones at the cellular level. Postgrad. Med. J. 40:448-456. 
14. FOLEY, G.E. and W.L. AYCOCK. 1944. Effect of Stilbestrol on experi-
mental streptococcus infection in mice. Endocrinol. 35:139-144. 
15. GERSHBERG, H., Z. JAVIER, and M. HULSE. 1964. Glucose tolerance in 
women receiving an ovulatory suppressant. Diabetes ~:378-385. 
16. HAINES, R.F. and A.G. JOHNSON, and H.G. PETERING. 1967. Variable 
influences of antitumor drugs and progestational agents on immune 
responses in rodents. Federation Proc. ~:935-94l. 
17. HELLER, J.H. (ed.). 1960. Reticuloendothelial Structure and Function • 
. p. 316-319. Ronald Press .Co., New York. 
42. 
18. HELLMAN, L.M. 1967. Safety of oral contraceptives. Texas Reports of 
BioI. Med. 25:318-333. 
19. HELLMAN, L.M., and H.J. EASTMAN. 1966. Obstetrics, p. 1068-1075. 
App1eton-Century-Crofts, New York. 
20. HIRSCH, J.G. and A.B. CHURCH. 1960. Studies of phagocytosis of Group A 
Streptococcus by polymorphonuclear 1eucocytes in vitro. J. Exptl. 
Med. 111:309-321. 
21. IGLESIAS, R. 1964. Hormones and tumors. Proc. of the 2nd Int. Congo 
Endocrinol. g: 1072-1084'. 
22. JUCHAU, M.R. and J.R. FOUTS. 1966. Effects of Norethynodrel and pro-
gesterone on hepatic microsomal drug metabolizing enzyme, systems. 
Biochem. Pharm. 15:891-898. 
23. KAPPAS, A. 1958. Biologic actions of some natural steroids on the 
liver. New England J. Med. 273:378-384. 
24. KASS, E.H. and M. FINLAND. 1953. Adrenocortical hormones in infection 
and immunity. Ann. Rev. Microbiol. 1:361-388. 
25. LEACH, R.B. and R.R. MARGULIS. 1965. Inhibition of adrenocortical 
responsiveness during progestin therapy. Am. J. Obstetric Gynecol. 
92:762-768. 
26. LESTER, G. and O. HECHTER. 1958. Effect of DOCA on the growth of 
microorganisms. J. Bacteriol. 76:365-367. 
27. L.IPSCHUTZ, A. and R. IGLESIAS, V.I. PANASEVICH, and S. SALINAS. 1966. 
Granulosa-cell tumours induced in mice by progesterone. Brit. J. 
Cancer 21:144-152. 
43. 
2S. LIPSCHUTZ, A., R. IGLESIAS, V.I. PANASEVICH, and S. SALINAS. 1967. 
Ovarian tumours and other ovarian changes induced in mice by two 
19-Nor-contraceptives. Brit. J. Cancer 21:153-159. 
29. LIPSCHUTZ, A., R. IGLESIAS, V.I. PANASEVICH and S. SALINAS. 1967. 
Pathological changes induced in the uterus of mice with the prolonged 
administration of progesterone and 19-Nor-contraceptives. Brit. J. 
Cancer 21:160-165. 
30. LURIE, M.B., S. ABRAMSON, and M.J. ALLISON. 1949. Constitutional 
factors in resistance to infection. Am. Rev. Tuberc. 22:168-218. 
31. MANKOWSKI, F. and T. ZBIGNIEW. 1954. Influence of various sex hormones 
on experimental fungus infection. Antibiot. and Chemother. ~: 
1100-11'OS. 
32. MARGULIS, R.R., J.L. AMBRUS, I.B. MINK, and J. STRYLEE. 1965. pro-
gestational agents and blood coagulation. Am. J. Obstetric. 
Gyneco1. 93:161-169. 
33. NICOL, T., B.L.J. BILBEY. 1958. Substances depres,sing the phagocytic 
activity of the reticuloendothelial system. Nature 182:606. 
34. NICOL, T., B.L.J. BILBEY, L.M. CHARLES, J.L. CORDINGLEY, and B.V. ROBERTS. 
1964. Oestrogen: the natural stimulant of body defenses. 
J. Endocrino1. 30:277-289. 
35. NICOL, T., D.C. QUANTOCK, and B.V. ROBERTS. 1966. Stimulation of 
phagocytosis in relation t9 the mechanism of action of adjuvants. 
Nature 209:1142-1143. 
44. 
36. OREN, R., A.E. FARNBAM, K. SAITO, E. MILOFSKY, and M.L. KARNOVSKY. 
1963. Metabolic patterns in 3 types of phagocytizing cells. 
J. Cell. Bio1. 17:487-501. 
37. PARISH, L.C. and J.A. WITKOWSKI. 1967. The enigma of acne therapy: 
the acne abcess. Am. J. Med. Sci. 254:19-26. 
38. ROGERS, D.H. 1953. Most mechanisms which act to remove bacteria from 
the bloodstream. Bacterio1. Rev. 24:50-66. 
39. ROGERS, D.E. and R. TOMPSETT. 1952. Survival of S. aureus within 
human 1eucocytes. J. Expt1. Med. 21:209-229. 
40. ROSSI, G.V~ 1966. Side-effects and possible complications of oral 
contraceptive drugs. Am. J. Pharmaco1. ~:127-l36. 
41. SCHAYER, R.W. 1967. A unified theory of glucocorticoid action. 
Persp. Bio1. Med. 10:409-418. 
42. SHAYEGANI, M.G. and F.A. KAPRAL. 1962. Eventual intracellular destruc-
tion of Staphylococcus aureus by mononuclear cells. J. Gen. 
Microbio1. ~:637-642. 
43. SHAYEGANI, M.G. and F.A. KAPRAL. 1962. Immediate fate of S. aureus 
after phagocytosis. J. Gen. Microbio1. 29:625-636. 
44. SONNEWIRTH, A.C. 1963. Gram-positive and Gram-negative cocci, p. 537-
545. Hematological Staining, p. 1143. In F.S. Reitman and A.C. 
Sonnenwirth (ed.), Gradwohl's Clinical and Laboratory Methods and 
Diagnosis, vols. 1 and 2 •. C. V. Mosby Co., St. Louis. 
, 
45. SPRUNT, P.H., S. McDEARMAN, and J. RAPER. 1938. Studies on the rela-
tionship of the sex hormones to infections. J. Expt1. Med. 67:159-168. 
46. STRITTMATTER, C.F. 1962. Site of steroid hormone inhibition in the 
respiratory enzyme chain. J. Cell. Compo Physio1. 60:23-32. 
47. STRAUSS, J.S. and P.E. POCHI. 1964. Effect of cyclic progestin-
estrogen therapy on sebum and acne in women. J. Am. Med. Assoc. 
190:815-819. 
48. TOMKINS, G.M. and E.S. MARIVELL. 1963. Some aspects of steroid hormone 
action. Ann. Rev. Biochem. 32:677-708. 
49. VAN HAAM, E. and I. ROSENFELD. 1942. Effect of various sex hormones 
on experimental pneumococcus infection in mice. J. Infect. Dis. 
70:243~247. 
50. VARRICCHIO, F., D.R. SANADI. 1967. Inhibition of mitochondrial respir-
ation by progesterone and an azasteroid. Arch. Biochem. Biophys. 
121:187-197. 
51. WEINSTEIN, L. 1939. Effect of estrogenic hormone and ovariectomy on 
the normal antibody content of the serum of mature rabbits. 
Yale J. Bio1. Med. 11:169-177. 
52. WEINSTEIN, L. 1939. Prophylaxis of experimental anthrax infection 
with various hormone preparations. Yale J. Bio1. Med. !l:369-375. 
53. WHITE, A., P. HANDLER, and E.L. SMITH. 1964. Principles of Biochem-
istry, p. 863-867. McGraw-Hill Book Co., New York. 
46. 
54. YOTIS, W.W. 1967. In vivo and in vitro action of Norethindrone on 
staphylococci. J. Bacterio1. 94:1353-1358. 
55. YOTIS~ W.W. and R. STANKE. 1966. Bacteriostatic action of Progesterone 
on staphylococci and other microorganisms. J. Bacteriol. 2!: 
1285-1289. 
47. 
